Lupin slips 9% in two days, hits 52-week low on disappointing Q3 results

In the past six months, the stock has shed nearly 30 per cent, as compared to a 7 per cent rise in the S&P BSE Sensex.

Shares of Lupin dipped 6 per cent to Rs 816.25 in Monday’s intra-day trade, falling 9 per cent in the past two trading sessions after the drugmaker reported lower-than-expected margins and net profit in December quarter (Q3FY22) due to one-time expenses related to residual metformin returns and provision for aged stock returns of Oseltamivir.

The stock of the pharmaceutical company dropped below its previous 52-week low of Rs 854 touched on December 20, 2021. The stock trades at its lowest level since May 2020. In the past six months, the stock has shed nearly 30 per cent, as compared